EN
HI
Summary
As of 10 Nov, 2026, Mankind Pharma stock price is ₹2668.3. During the trading session, the stock has moved between an intraday low of ₹2585.20 and an intraday high of ₹2705.00. Over the last 52 weeks, Mankind Pharma has traded between ₹1909.70 and ₹2705.00.
The stock has recorded a trading volume of 15,15,775 shares,. Its Average Traded Price (ATP) is ₹2662.05, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹2668.30.
Mankind Pharma has an upper circuit limit of ₹2841.10 and a lower circuit limit of ₹2324.70. The total value traded stands at ₹403.51 CR, and the delivery percentage for the day is 39.59%.
The stock is currently traded with a market lot size of 1. Mankind Pharma also offers a dividend yield of 0.04%.
Mankind Pharma Share Price Chart
Mankind Pharma Share Key Metrics
Volume
15.16 L
Market Cap
110212.82 CR
LTQ@LTP
2@2668.30
ATP
2662.05
Var Margin
15.18 %
Circuit Range
2324.7-2841.1
Delivery %
39.59 %
Value
403.51 CR
ASM/GSM
No
Market Lot
1
Mankind Pharma Fundamentals
P/E Ratio
47.46
P/B Ratio
6.05
Div. Yield
0.04
Sector P/E
40.79
Sector P/B
3.79
Sec. Div. Yield
0.53
Mankind Pharma Resistance and Support
Pivot 2571.13
Resistance
First Resistance
2605.36
Second Resistance
2627.83
Third Resistance
2662.06
Support
First Support
2548.66
Second Support
2514.43
Third Support
2491.96
Mankind Pharma Futures & Options
Mankind Pharma Option Chain
View Price, OI, Greeks & More...
23NOV26
2665.00
70.80 (2.73%)
29DEC26
2684.20
77.00 (2.95%)
25JAN27
2688.00
79.00 (3.03%)
MANKIND|23NOV26 CE 2660.00
72.45
31.35 (76.28%)
MANKIND|23NOV26 PE 2680.00
76.45
-258.4 (-77.17%)
Mankind Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 09 2026 | 2600 | 2668.3 | 3.31% | 2705 | 2585.2 |
| Sun Nov 08 2026 | 2550 | 2582.89 | 1.69% | 2593.6 | 2536.89 |
| Fri Nov 06 2026 | 2508 | 2540 | 0.87% | 2545 | 2489 |
Mankind Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-26 | Quarterly Results |
| 2026-07-30 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-03 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-07-31 | Quarterly Results & Interim Dividend |
| 2025-05-21 | Audited Results |
| 2025-01-23 | Quarterly Results |
| 2024-11-05 | Quarterly Results |
Mankind Pharma News
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Mankind Pharma's board approved the amalgamation of its wholly-owned subsidiaries, Prolijune Lifesciences and Pavi Buildwell, into the parent company. The scheme aims to simplify and rationalize the group structure, with the appointed date set as April 1, 2027.
Oct 26 2026 15:24:04
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Mankind Pharma board approved the amalgamation of wholly owned subsidiaries Prolijune Lifesciences and Pavi Buildwell into the company. The appointed date for the scheme is April 1, 2027. The move aims to streamline the corporate structure and improve operational efficiencies.
Oct 26 2026 15:21:47
Read More
Mankind Pharma Management
| Name | Position |
|---|---|
| Hitesh Kumar Jain | Company Secretary & Compliance Officer |
| Ramesh Juneja | Chairman |
Mankind Pharma Similar Stocks
Lenskart Solutions Ltd.
718.80
-13.50 (1.84%)
Apollo Hospitals Enterprise Ltd.
8549.50
119.50 (1.42%)
Zydus Lifesciences Ltd.
1215.90
16.40 (1.37%)
Dr. Reddy's Laboratories Ltd.
1385.00
15.00 (1.09%)
Cipla Ltd.
1403.80
-2.00 (0.14%)
Aurobindo Pharma Ltd.
1855.30
51.30 (2.84%)
Lupin Ltd.
2025.00
28.00 (1.40%)
Max Healthcare Institute Ltd.
915.00
-11.00 (1.19%)
Manipal Health Enterprises Ltd.
665.15
6.75 (1.03%)
Glenmark Pharmaceuticals Ltd.
2671.10
76.20 (2.94%)
Mankind Pharma FAQs
The Buying Price of Mankind Pharma share is 2668.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Mankind Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Mankind Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Mankind Pharma shares is 47.46. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Mankind Pharma shares is 6.05. Useful to assess the stock's value relative to its book value.
To assess Mankind Pharma’s valuation compare Sector P/E, P/B which are 40.79 & 3.79 with sector averages, along with growth rates and financial metrics.
The Market Cap of Mankind Pharma is 110212.82 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Mankind Pharma share price is 2705.00 & 1909.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Mankind Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in MANKIND
